Skip to main content
18 search results for:

Risedronate 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 11-01-2022 | Osteoporosis | News | Article

    Hip fracture risk higher during risedronate versus alendronate drug holiday

    The risk for hip fracture is higher during a treatment break from risedronate than it is during a break from alendronate, study findings indicate.

  2. 27-10-2018 | Osteoporosis | Highlight | Teaser
    medwireNews@ACR/ARHP 2018

    Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

    Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

  3. play
    27-10-2018 | Denosumab | ACR/ARHP 2018 | Video

    Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

    Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

  4. 24-10-2018 | Osteoporosis | News | Article

    Two-year data support denosumab use in patients with glucocorticoid-induced osteoporosis

    Greater increases in bone mineral density seen with denosumab versus risedronate in glucocorticoid-treated patients with osteoporosis are sustained through 24 months, indicate phase III data.

  5. 12-04-2018 | Osteoporosis | News | Article

    Trial results back denosumab as a treatment option for glucocorticoid-induced osteoporosis

    Patients with glucocorticoid-induced osteoporosis who are treated with denosumab have greater improvements in bone mineral density than those treated with risedronate, phase III trial results suggest.

  6. 12-04-2018 | Osteoporosis | Highlight | Teaser
    medwireNews editor's pick

    Trial results back denosumab as a treatment option for glucocorticoid-induced osteoporosis

    Patients with glucocorticoid-induced osteoporosis who are treated with denosumab have greater improvements in bone mineral density than those treated with risedronate, phase III trial results suggest.

  7. 04-06-2018 | Osteoporosis | Review | Article

    Review of the guideline of the American College of Physicians on the treatment of osteoporosis

    Kanis, JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4504-y

  8. 17-05-2018 | Osteoporosis | Article

    Anti-osteoporosis drug use: Too little, too much, or just right? The HUNT study, Norway

    Hoff M et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4560-3

  9. 11-05-2018 | Osteoarthritis | Review | Article

    The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA

    Roemer FW et al. Nat Rev Rheumatol 2018; 14: 372–380. doi: 10.1038/s41584-018-0010-z

  10. 03-02-2018 | Osteoporosis | Article

    Bisphosphonate use after clinical fracture and risk of new fracture

    Bergman J, Nordström A, Nordström P. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-017-4367-7

  11. 30-06-2017 | Osteoporosis | Review | Article

    Using osteoporosis therapies in combination

    This review summarizes the evidence on using of osteoporosis drugs in combination and, with the exception of adding teriparatide to denosumab, finds little data to support using more than one drug at a time. McClung MR. Curr Osteoporos Rep 2017;15:343–352. doi:10.1007/s11914-017-0376-x

  12. 19-04-2017 | Osteoporosis | Review | Article

    UK clinical guideline for the prevention and treatment of osteoporosis

    This guideline, accredited by the National Institute of Health and Care Excellence, provides an overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management. Compston J, Cooper A, Cooper C et al. Arch Osteoporos 2017;12:43. doi:10.1007/s11657-017-0324-5

  13. 26-02-2017 | Osteoporosis | Book Chapter | Article

    New target sites for treatment of osteoporosis

    This chapter summarizes recent updates in the development of anti-osteoporotic agents, focusing on approaches based on the application of inorganic polymers and combination therapy. Müller WEG, Schröder HC, Wang X. In: Blue Biotechnology . Edited by Müller WEG, Schröder HC, Wang X. Springer International Publishing AG, 2017. doi:10.1007/978-3-319-51284-6_6

  14. 18-01-2016 | Osteoporosis | Article

    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis

    The authors assessed the efficacy of approved osteoporosis pharmacotherapies in preventing fracture and determined that teriparatide, risedronate, and etidronate led to a decreased vertebral fracture risk. Amiche MA et al. Osteoporos Int 2016;27:1989–1998. doi:10.1007/s00198-015-3476-4

  15. 12-07-2016 | Osteoporosis | Book Chapter | Article

    Medical treatment of age related osteoporosis

    An expert summary of available therapies and those on the horizon for patients with osteoporosis including vitamin D, bisphosphonates, selective estrogen receptor modulators, denosumab, and teriparatide. Wong EK-C, Kim LH-Y, Papaioannou A. In: Osteoporosis in Older Persons . Edited by Duque G, Kile DP. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-25976-5_12

  16. 28-04-2016 | Osteoporosis | Review | Article

    The management of osteoporosis in children

    An expert review of the manifestations of osteoporosis in childhood, recommendations for monitoring and prevention, and suggestions for when a child should be considered a candidate for therapy. Ward LM, Konji VN, & Ma J. Osteoporos Int 2016;27:2147–2179. doi:10.1007/s00198-016-3515-9

  17. 09-12-2015 | Osteoporosis | Review | Article

    Bisphosphonate treatment in osteoporosis: Optimal duration of therapy and the incorporation of a drug holiday

    In this study, Villa et al. postulate that the duration of drug holiday should be individualized for each patient and should be based on serial bone mass measurements, bone turnover rates, and fracture history. Villa JC, Gianakos A, & Lane JM. HSS Jrnl 2016;12:66–73. doi:10.1007/s11420-015-9469-1

  18. 03-09-2015 | Osteoporosis | Review | Article

    Cathepsin K inhibition: A new mechanism for the treatment of osteoporosis

    Doung et al. explore the potential advances of the inhibition of cathepsin K by odanacatib and determine whether it could be a novel mechanism of action for the treatment of osteoporosis. Duong LT, Leung AT, & Langdahl B. Calcif Tissue Int 2016;98:381–397. doi:10.1007/s00223-015-0051-0

  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.